Clinical Trial Update: A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec [Phase 2]

View source ↗

Summary

Clinical trial update describes a Phase 2 biomarker study of Aglatimagene Besadenovec in men with localized prostate cancer treated with radiotherapy, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Aglatimagene Besadenovec

Snippet

Sponsor: Candel Therapeutics, Inc. | Conditions: Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma) | Phase 2 | Status: RECRUITING